105 related articles for article (PubMed ID: 18058538)
1. Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
Liu X; Inomata M; Ogawara T; Saneyoshi M; Yamaguchi T
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1067-71. PubMed ID: 18058538
[TBL] [Abstract][Full Text] [Related]
2. Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides.
Yamaguchi T; Liu X; Ogawara T; Inomata M; Saneyoshi M
Nucleic Acids Symp Ser (Oxf); 2006; (50):271-2. PubMed ID: 17150922
[TBL] [Abstract][Full Text] [Related]
3. 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
Liu X; Takahashi H; Harada Y; Ogawara T; Ogimura Y; Mizushina Y; Saneyoshi M; Yamaguchi T
Nucleic Acids Res; 2007; 35(21):7140-9. PubMed ID: 17942424
[TBL] [Abstract][Full Text] [Related]
4. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells.
Kurashina Y; Liu X; Kato C; Inoue N; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2009; (53):249-50. PubMed ID: 19749354
[TBL] [Abstract][Full Text] [Related]
5. Influence of nucleoside analogue treatment on telomere length and TRF2 amount in human HL60 cells.
Liu X; Liu J; Ogawara T; Kurashina Y; Yashi R; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2007; (51):253-4. PubMed ID: 18029682
[TBL] [Abstract][Full Text] [Related]
6. Synthetic nucleosides and nucleotides. 43. Inhibition of vertebrate telomerases by carbocyclic oxetanocin g (C.OXT-G) triphosphate analogues and influence of C.OXT-G treatment on telomere length in human HL60 cells.
Yamaguchi T; Saneyoshi M; Takahashi H; Hirokawa S; Amano R; Liu X; Inomata M; Maruyama T
Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):539-51. PubMed ID: 16838844
[TBL] [Abstract][Full Text] [Related]
7. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on amounts of TERT and POT1 in human HL60 cells.
Liu X; Ogawara T; Kurashina Y; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2008; (52):491-2. PubMed ID: 18776468
[TBL] [Abstract][Full Text] [Related]
8. Telomere shortening in human HL60 cells by treatment with deoxyguanosine analogs.
Yamaguchi T; Takahashi H; Harada Y; Yoshikawa M; Iyono S; Inomata M; Maruyama T; Saneyoshi M
Nucleic Acids Symp Ser (Oxf); 2004; (48):187-8. PubMed ID: 17150541
[TBL] [Abstract][Full Text] [Related]
9. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of HIV reproduction in cell culture by 5'-phosphonates of 3'-azido-2',3'-dideoxynucleosides].
Tarusova NB; Khorlin AA; Kraevskiĭ AA; Korneeva MN; Nosik DN; Kruglov IV; Galegov GA; Bibilashvili RSh
Mol Biol (Mosk); 1989; 23(6):1716-24. PubMed ID: 2633042
[TBL] [Abstract][Full Text] [Related]
11. Influence of long-term treatment with cytosine arabinoside on telomere length in human HL60 cells.
Yamaguchi T; Kazama K; Takashima J; Ogawara T; Iyono S; Inomata M; Saneyoshi M
Nucleic Acids Symp Ser (Oxf); 2005; (49):289-90. PubMed ID: 17150747
[TBL] [Abstract][Full Text] [Related]
12. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
Strahl C; Blackburn EH
Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
[TBL] [Abstract][Full Text] [Related]
14. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs.
Malerba I; Gribaldo L; Diodovich C; Carloni M; Meschini R; Bowe G; Collotta A
Toxicol In Vitro; 2005 Jun; 19(4):523-32. PubMed ID: 15826810
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP
Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
[TBL] [Abstract][Full Text] [Related]
19. [Progress in telomerase and the inhibitors].
Zhou Y; Gong XG
Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):604-7. PubMed ID: 11910748
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
